Vimarsana
Biggest News Aggregation in the World

Page 23 - Pharma Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Inc Today - Breaking & Trending Today

ESSA Pharma (EPIX) to Release Quarterly Earnings on Friday - Vimarsana News

ESSA Pharma (EPIX) to Release Quarterly Earnings on Friday

ESSA Pharma (NASDAQ:EPIX – Get Free Report) (TSE:EPI) will be posting its quarterly earnings results on Friday, February 9th. ESSA Pharma (NASDAQ:EPIX – Get Free Report) (TSE:EPI) last announced its quarterly earnings results on Tuesday, December 12th. The company reported ($0.12) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.22) by […]

Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million - Vimarsana News

Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million

09.02.2024 - SOLANA BEACH, Calif., Feb. 09, 2024 (GLOBE NEWSWIRE) - Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI (metoclopramide) nasal ... Seite 1

Evoke Pharma Prices Public Offering Of Up To $30 Mln Of Shares - Vimarsana News

Evoke Pharma Prices Public Offering Of Up To $30 Mln Of Shares

(RTTNews) - Evoke Pharma, Inc. (EVOK), a company focused on treatments for gastrointestinal diseases, announced on Friday that it has priced an un...

ESSA Pharma Inc Executive Peter Virsik Sells 72,782 Shares - Vimarsana News

ESSA Pharma Inc Executive Peter Virsik Sells 72,782 Shares

On February 6, 2024, Peter Virsik, the COO of ESSA Pharma Inc (NASDAQ:EPIX), executed a sale of 72,782 shares of the company's stock, according to a recent SEC Filing.

Source: yahoo.com
Telix Signs Agreement to Acquire QSAM Biosciences and Its Bone Cancer Targeting Platform - QSAM Biosciences (OTC:QSAM) - Vimarsana News

Telix Signs Agreement to Acquire QSAM Biosciences and Its Bone Cancer Targeting Platform - QSAM Biosciences (OTC:QSAM)

MELBOURNE, Australia, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has entered into an agreement to acquire QSAM Biosciences, Inc. (OTC:QSAM) and its